• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声匀浆处理浆膜剥离提高肝硬化大鼠胎肝肝面种植。

Serous Membrane Detachment with Ultrasonic Homogenizer Improves Engraftment of Fetal Liver to Liver Surface in a Rat Model of Cirrhosis.

机构信息

Department of Regenerative Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.

Division of Regenerative Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan.

出版信息

Int J Mol Sci. 2021 Oct 27;22(21):11589. doi: 10.3390/ijms222111589.

DOI:10.3390/ijms222111589
PMID:34769019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8584093/
Abstract

Liver transplantation is the most effective treatment for end-stage cirrhosis. However, due to serious donor shortages, new treatments to replace liver transplantation are sorely needed. Recent studies have focused on novel therapeutic methods using hepatocytes and induced pluripotent stem cells, we try hard to develop methods for transplanting these cells to the liver surface. In the present study, we evaluated several methods for their efficiency in the detachment of serous membrane covering the liver surface for transplantation to the liver surface. The liver surface of dipeptidyl peptidase IV (DPPIV)-deficient rats in a cirrhosis model was detached by various methods, and then fetal livers from DPPIV-positive rats were transplanted. We found that the engraftment rate and area as well as the liver function were improved in rats undergoing transplantation following serous membrane detachment with an ultrasonic homogenizer, which mimics the Cavitron Ultrasonic Surgical Aspirator (CUSA), compared with no detachment. Furthermore, the bleeding amount was lower with the ultrasonic homogenizer method than with the needle and electric scalpel methods. These findings provide evidence that transplantation to the liver surface with serous membrane detachment using CUSA might contribute to the development of new treatments for cirrhosis using cells or tissues.

摘要

肝移植是治疗终末期肝硬化最有效的方法。然而,由于严重的供体短缺,迫切需要新的治疗方法来替代肝移植。最近的研究集中在使用肝细胞和诱导多能干细胞的新型治疗方法上,我们努力开发将这些细胞移植到肝表面的方法。在本研究中,我们评估了几种用于分离覆盖肝表面的浆膜以移植到肝表面的方法的效率。通过各种方法分离二肽基肽酶 IV(DPPIV)缺陷型大鼠肝硬化模型中的肝表面,然后移植 DPPIV 阳性大鼠的胎肝。我们发现,与未分离相比,使用模拟 Cavitron Ultrasonic Surgical Aspirator(CUSA)的超声匀浆器进行浆膜分离后,移植大鼠的植入率、面积和肝功能均得到改善。此外,与针和电刀方法相比,超声匀浆器法的出血量更低。这些发现为使用细胞或组织进行肝表面移植结合浆膜分离的 CUSA 提供了证据,可能有助于开发治疗肝硬化的新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/8584093/efd18da00ba8/ijms-22-11589-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/8584093/be2e9e3b5709/ijms-22-11589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/8584093/2faa0250f728/ijms-22-11589-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/8584093/539a2f882e2b/ijms-22-11589-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/8584093/2a27df08510b/ijms-22-11589-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/8584093/efd18da00ba8/ijms-22-11589-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/8584093/be2e9e3b5709/ijms-22-11589-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/8584093/2faa0250f728/ijms-22-11589-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/8584093/539a2f882e2b/ijms-22-11589-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/8584093/2a27df08510b/ijms-22-11589-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54cc/8584093/efd18da00ba8/ijms-22-11589-g005.jpg

相似文献

1
Serous Membrane Detachment with Ultrasonic Homogenizer Improves Engraftment of Fetal Liver to Liver Surface in a Rat Model of Cirrhosis.超声匀浆处理浆膜剥离提高肝硬化大鼠胎肝肝面种植。
Int J Mol Sci. 2021 Oct 27;22(21):11589. doi: 10.3390/ijms222111589.
2
Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration.在2-乙酰氨基芴/部分肝切除诱导的肝再生过程中,骨髓源性肝卵圆细胞分化为肝细胞。
Gastroenterology. 2007 Mar;132(3):1077-87. doi: 10.1053/j.gastro.2007.01.001. Epub 2007 Jan 5.
3
Preoperative hepatocyte transplantation improves the survival of rats with nonalcoholic steatohepatitis-related cirrhosis after partial hepatectomy.术前肝细胞移植可提高非酒精性脂肪性肝炎相关性肝硬化大鼠在部分肝切除术后的存活率。
Cell Transplant. 2014;23(10):1243-54. doi: 10.3727/096368913X668645.
4
Two different methods for donor hepatic transection: cavitron ultrasonic surgical aspirator with bipolar cautery versus cavitron ultrasonic surgical aspirator with radiofrequency coagulator-A randomized controlled trial.两种不同的供肝切断方法:双极电凝超声外科吸引器与射频凝固超声外科吸引器——一项随机对照试验
Liver Transpl. 2009 Jan;15(1):102-5. doi: 10.1002/lt.21658.
5
Repopulation of the fibrotic/cirrhotic rat liver by transplanted hepatic stem/progenitor cells and mature hepatocytes.肝星状细胞/肝纤维化大鼠肝再生的移植的肝干细胞/祖细胞和成熟肝细胞。
Hepatology. 2014 Jan;59(1):284-95. doi: 10.1002/hep.26615. Epub 2013 Nov 18.
6
Engraftment of syngeneic and allogeneic endothelial cells, hepatocytes and cholangiocytes into partially hepatectomized rats previously treated with mitomycin C.将同基因和异基因内皮细胞、肝细胞和胆管细胞移植到先前用丝裂霉素C处理过的部分肝切除大鼠体内。
Transplantation. 2009 Aug 27;88(4):486-95. doi: 10.1097/TP.0b013e3181b0b98a.
7
Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine.在用倒千里光碱处理的大鼠中,在无外源性生长刺激的情况下,通过移植肝细胞进行大规模肝脏置换。
Am J Pathol. 2001 Feb;158(2):771-7. doi: 10.1016/s0002-9440(10)64019-9.
8
Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation.肝脏照射可增强肝细胞移植后供体细胞的植入。
Hepatology. 2009 Jan;49(1):258-67. doi: 10.1002/hep.22573.
9
Direct hyperplasia does not enhance the kinetics of liver repopulation in a new model of hepatocyte transplantation in the rat.在大鼠肝细胞移植的新模型中,直接增生并未增强肝脏再填充的动力学。
J Hepatol. 1999 Aug;31(2):354-9. doi: 10.1016/s0168-8278(99)80235-9.
10
Liver repopulation after hepatocellular transplantation: integration and interaction of transplanted hepatocytes in the host.肝细胞移植后的肝脏再填充:移植的肝细胞在宿主体内的整合与相互作用。
Cell Transplant. 2005;14(1):31-40. doi: 10.3727/000000005783983322.

引用本文的文献

1
A novel approach for hepatocyte transplantation at the liver surface.一种在肝脏表面进行肝细胞移植的新方法。
Cell Transplant. 2025 Jan-Dec;34:9636897251329308. doi: 10.1177/09636897251329308. Epub 2025 Apr 10.

本文引用的文献

1
Transplantation of fetal liver tissue coated by ultra-purified alginate gel over liver improves hepatic function in the cirrhosis rat model.超纯藻酸盐凝胶包裹胎肝组织移植可改善肝硬化大鼠模型的肝功能。
Sci Rep. 2020 May 19;10(1):8231. doi: 10.1038/s41598-020-65069-y.
2
Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.两种不同剂量辛伐他汀联合利福昔明治疗失代偿期肝硬化的安全性(LIVERHOPE-SAFETY):一项随机、双盲、安慰剂对照、2 期临床试验。
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):31-41. doi: 10.1016/S2468-1253(19)30320-6. Epub 2019 Oct 10.
3
Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study.
自体干细胞移植治疗失代偿期肝硬化的疗效与安全性:一项回顾性队列研究。
World J Stem Cells. 2018 Oct 26;10(10):138-145. doi: 10.4252/wjsc.v10.i10.138.
4
Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis.基于干细胞的肝硬化学治疗的当前观点。
Can J Gastroenterol Hepatol. 2018 Jan 29;2018:4197857. doi: 10.1155/2018/4197857. eCollection 2018.
5
Human hepatocyte transplantation for liver disease: current status and future perspectives.人肝细胞移植治疗肝脏疾病:现状与展望。
Pediatr Res. 2018 Jan;83(1-2):232-240. doi: 10.1038/pr.2017.284. Epub 2017 Dec 6.
6
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.等待肝移植的肝硬化或肝衰竭患者中丙型肝炎病毒感染、非酒精性脂肪性肝炎和酒精性肝病患病率的变化。
Gastroenterology. 2017 Apr;152(5):1090-1099.e1. doi: 10.1053/j.gastro.2017.01.003. Epub 2017 Jan 11.
7
Treatment of Patients with Cirrhosis.肝硬化患者的治疗
N Engl J Med. 2016 Aug 25;375(8):767-77. doi: 10.1056/NEJMra1504367.
8
Vascularized and Complex Organ Buds from Diverse Tissues via Mesenchymal Cell-Driven Condensation.通过间充质细胞驱动的凝聚作用从多种组织中获得血管化和复杂器官芽。
Cell Stem Cell. 2015 May 7;16(5):556-65. doi: 10.1016/j.stem.2015.03.004. Epub 2015 Apr 16.
9
Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis.简明综述:间充质干细胞治疗急性肝衰竭和肝硬化的治疗潜力。
Stem Cells. 2014 Nov;32(11):2818-23. doi: 10.1002/stem.1818.
10
NAFLD, NASH and liver cancer.非酒精性脂肪性肝病、非酒精性脂肪性肝炎和肝癌。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):656-65. doi: 10.1038/nrgastro.2013.183. Epub 2013 Oct 1.